Association of a functional NOS1 promoter repeat with alzheimer's disease in the VITA cohort

Journal of Alzheimer's Disease

Volumn 23, Issue 2, 2011, Pages 327-333

  Reif, Andreas ^a,b   Herterich, Sabine ^a   Wichart, Ildiko ^c   Rainer, Michael K ^d   Jungwirth, Susanne ^d   Danielczyk, Walter ^d   Deckert, Jürgen ^a   Tragl, Karl Heinz ^d   Riederer, Peter ^a   Fischer, Peter ^d,e  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Alzheimer's disease; genetics; neuronal nitric oxide synthase (NOS1); polymorphism; risk factor; VITA study

Indexed keywords

APOLIPOPROTEIN E4; NEURONAL NITRIC OXIDE SYNTHASE;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; LATE ONSET ALZHEIMER DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT;

EID: 79951561656     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-101491     Document Type: Article

References (36)

1. Bertram L, Tanzi RE (2008) Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9, 768-778.
2. Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, Zismann VL, Beach TG, Leung D, Bryden L, Halperin RF, Marlowe L, Kaleem M, Walker DG, Ravid R, Heward CB, Rogers J, Papassotiropoulos A, Reiman EM, Hardy J, Stephan DA (2007) A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry 68, 613-618. (Pubitemid 46663046)
3. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K,Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schürmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van BroeckhovenC,Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N,Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, Nat Genet 41, 1088-1093.
4. Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Liang WS, Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos A, Stephan DA (2007) GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 54, 713-720. (Pubitemid 46843528)
5. Li H,Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, Hosford D, Barnes MR, Briley JD, Borrie M, Coletta N, Delisle R, Dhalla D, Ehm MG, Feldman HH, Fornazzari L, Gauthier S, Goodgame N, Guzman D, Hammond S, Hollingworth P, Hsiung GY, Johnson J, Kelly DD, Keren R, Kertesz A, King KS, Lovestone S, Loy-English I, Matthews PM, Owen MJ, Plumpton M, Pryse-Phillips W, Prinjha RK, Richardson JC, Saunders A, Slater AJ, St George-Hyslop PH, Stinnett SW, Swartz JE, Taylor RL, Wherrett J, Williams J, Yarnall DP, Gibson RA, Irizarry MC, Middleton LT, Roses AD (2008) Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 65, 45-53.
6. Blum-Degen D, Heinemann T, Lan J, Pedersen V, Leblhuber F, Paulus W, Riederer P, Gerlach M (1999) Characterization and regional distribution of nitric oxide synthase in the human brain during normal ageing. Brain Res 834, 128-135. (Pubitemid 29332017)
7. Malinski T (2007) Nitric oxide and nitroxidative stress in Alzheimer's disease. J Alzheimers Dis 11, 207-218. (Pubitemid 47018067)
8. Togo T, Katsuse O, Iseki E (2004) Nitric oxide pathways in Alzheimer's disease and other neurodegenerative dementias. Neurol Res 26, 563-566. (Pubitemid 38879240)
9. Law A, Gauthier S, Quirion R (2001) Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Rev 35, 73-96. (Pubitemid 32201877)
10. Marcourakis T, Bahia VS, Kawamoto EM, Munhoz CD, Gorjao R, Artes R, Kok F, Caramelli P, Nitrini R, Curi R, Scavone C (2008) Apolipoprotein E genotype is related to nitric oxide production in platelets. Cell Biochem Funct 62, 852-858.
11. Colton CA, Needham LK, Brown C, Cook D, Rasheed K, Burke JR, Strittmatter WJ, Schmechel DE, Vitek MP (2004) APOE genotype-specific differences in human and mouse macrophage nitric oxide production. J Neuroimmunol 147, 62-67. (Pubitemid 38114948)
12. Bros M, Boissel JP, Godtel-Armbrust U, Forstermann U (2006) Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences. Genomics 87, 463-473.
13. Xie J, Roddy P, Rife TK, Murad F, Young AP (1995) Two closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription. Proc Natl Acad Sci U S A 92, 1242-1246.
14. Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, Wienker T, Topner T, Fritzen S, Walter U, Schmitt A, Fallgatter AJ, Lesch KP (2006) A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 11, 286-300.
15. Reif A, Jacob CP, Rujescu D, Herterich S, Lang S, Gutknecht L, Baehne CG, Strobel A, Freitag CM, Giegling I, Romanos M, Hartmann A, Rosler M, Renner TJ, Fallgatter AJ, RetzW, Ehlis AC, Lesch KP (2009) Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry 66, 41-50.
16. Galimberti D, Scarpini E,Venturelli E, Strobel A, Herterich S, Fenoglio C, Guidi I, Scalabrini D, Cortini F, Bresolin N, Lesch KP, Reif A (2008) Association of a NOS1 promoter repeat with Alzheimer's disease. Neurobiol Aging 29, 1359-1365. (Pubitemid 351970600)
17. Fischer P, Jungwirth S, KramplaW,Weissgram S, Kirchmeyr W, SchreiberW, Huber K, Rainer M, Bauer P,TraglKH(2002) Vienna Transdanube Aging "VITA": study design, recruitment strategies and level of participation. J Neural Transm Suppl 62, 105-116. (Pubitemid 37046658)
18. Blasko I, Kemmler G, Krampla W, Jungwirth S, Wichart I, Jellinger K, Tragl KH, Fischer P (2005) Plasma amyloid beta protein 42 in non-demented persons aged 75 years: effects of concomitant medication and medial temporal lobe atrophy. Neurobiol Aging 26, 1135-1143. (Pubitemid 40726005)
19. Grunblatt E, Schlosser R, Fischer P, Fischer MO, Li J, Koutsilieri E, Wichart I, Sterba N, Rujescu D, Moller HJ, Adamcyk W, Dittrich B, Muller F, Oberegger K, Gatterer G, Jellinger KJ, Mostafaie N, Jungwirth S, Huber K, Tragl KH, DanielczykW, Riederer P (2005) Oxidative stress related markers in the "VITA" and the centenarian projects. Neurobiol Aging 26, 429-438. (Pubitemid 40093926)
20. Jungwirth S, Zehetmayer S, Bauer P,Weissgram S, Tragl KH, Fischer P (2009) Screening for Alzheimer's dementia at age 78 with short psychometric instruments. Int Psychogeriatr 21, 548-559.
21. Grunblatt E, Hupp E, Bambula M, Zehetmayer S, Jungwirth S, Tragl KH, Fischer P, Riederer P (2006) Association study of BDNF and CNTF polymorphism to depression in nondemented subjects of the "VITA" study. J Affect Disord 96, 111-116. (Pubitemid 44548043)
22. Grunblatt E, Loffler C, Zehetmayer S, Jungwirth S, Tragl KH, Riederer P, Fischer P (2006) Association study of the 5-HTTLPR polymorphism and depression in 75-year-old nondemented subjects from the Vienna Transdanube Aging (VITA) study. J Clin Psychiatry 67, 1373-1378. (Pubitemid 44583384)
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
24. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al. (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260. (Pubitemid 23060253)
25. Liang X, Schnetz-Boutaud N, Kenealy SJ, Jiang L, Bartlett J, Lynch B, Gaskell PC, Gwirtsman H, McFarland L, Bembe ML, Bronson P, Gilbert JR, Martin ER, Pericak-Vance MA, Haines JL (2006) Covariate analysis of late-onset Alzheimer disease refines the chromosome 12 locus. Mol Psychiatry 11, 280-285.
26. Rife T, Rasoul B, Pullen N, Mitchell D, Grathwol K, Kurth J (2009) The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease. J Neurosci Res 87, 2319-2325.
27. Lo HS, Hogan EL, SoongBW(2002) 5′-flanking region polymorphism of the neuronal nitric oxide synthase gene with Parkinson's disease in Taiwan. J Neurol Sci 194, 11-13. (Pubitemid 34055727)
28. Saur D, Vanderwinden JM, Seidler B, Schmid RM, De Laet MH, Allescher HD (2004) Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis. Proc Natl Acad Sci U S A 101, 1662-1667. (Pubitemid 38234211)
29. Snyder SH, Ferris CD (2000) Novel neurotransmitters and their neuropsychiatric relevance. Am J Psychiat 157, 1738-1751.
30. Thorns V, Hansen L, Masliah E (1998) nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease. Exp Neurol 150, 14-20. (Pubitemid 28146418)
31. Luth HJ, Munch G, Arendt T (2002) Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res 953, 135-143. (Pubitemid 35217815)
32. Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RA (1998) Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 18, 8126-8132. (Pubitemid 28464991)
33. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, Lipton SA (2009) S-nitrosylation of Drp1 mediates betaamyloid- related mitochondrial fission and neuronal injury. Science 324, 102-105.
34. Stroissnigg H, Trancikova A, Descovich L, Fuhrmann J, KutscheraW,Kostan J, Meixner A, Nothias F, Propst F (2007) S-nitrosylation of microtubule- associated protein 1B mediates nitric-oxide-induced axon retraction. Nat Cell Biol 9, 1035-1045. (Pubitemid 47338143)
35. Tsang AH, Lee YI, Ko HS, Savitt JM, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM, Chung KK (2009) S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease. Proc Natl Acad Sci U S A 106, 4900-4905.
36. Bennett BM, Reynolds JN, Prusky GT, Douglas RM, Sutherland RJ, Thatcher GR (2007) Cognitive deficits in rats after forebrain cholinergic depletion are reversed by a novel NO mimetic nitrate ester. Neuropsychopharmacology 32, 505-513.